Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data

Published 2012 View Full Article

Authors

Keywords

Journal

Therapeutics and Clinical Risk Management

Volume -, Issue -, Pages 313

Publisher

Dove Medical Press Ltd.

Online

2012-06-20

DOI

10.2147/tcrm.s31347

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Therapeutics and Clinical Risk Management

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Become a Peeref-certified reviewer